VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572,536 | +19.4% | 21,276 | +33.6% | 0.22% | -5.3% |
| Q2 2023 | $479,561 | -30.6% | 15,927 | -25.4% | 0.23% | -18.6% |
| Q1 2023 | $690,671 | +12.0% | 21,350 | -0.8% | 0.28% | +8.1% |
| Q4 2022 | $616,934 | +16.8% | 21,526 | -1.8% | 0.26% | +4.0% |
| Q3 2022 | $528,000 | -12.1% | 21,928 | -0.0% | 0.25% | -11.4% |
| Q2 2022 | $601,000 | -32.0% | 21,938 | -4.8% | 0.28% | -25.1% |
| Q1 2022 | $884,000 | -27.3% | 23,052 | -39.3% | 0.37% | -22.9% |
| Q4 2021 | $1,216,000 | -48.0% | 37,958 | -52.2% | 0.48% | -54.8% |
| Q3 2021 | $2,339,000 | +3.5% | 79,376 | +19.4% | 1.07% | +4.9% |
| Q2 2021 | $2,259,000 | – | 66,474 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |